What is the global market size of Oncology Market?

Oncology Market size was valued at USD 286.04 billion in 2021 and is poised to grow from USD 309.3 billion in 2022 to USD 581.25 billion by 2030, growing at a CAGR of 8.2% in the forecast period (2023-2030).

What is the key driver of Global Oncology Market?

The oncology market growth is attributed to the rising prevalence of cancer across the globe. Cancer has become the second greatest cause of death in the world, trailing only cardiovascular disease. This is caused by factors such as cigarette use, changing dietary patterns, and an extended post-reproductive lifespan. Cancer, for example, is a growing burden, with the number of new cancer cases expected to rise from 18.1 million in 2018 to 29.4 million by 2040, according to the World Health Organization (WHO). As a result, the rising prevalence of cancer is predicted to drive demand for worldwide oncology cancer medications during the forecast period. Furthermore, increased cancer awareness among the people is expected to benefit the global market in the approaching years.

What is the key market trend for Global Oncology Market?

The expansion of the oncology market is aided by the growing focus on R&D to increase adoption of advanced drug therapies. The goals of cancer treatment are to cure the disease, prolong survival, and improve quality of life. Immune cells are crucial in tumor growth. As a result, boosting immune responses to malignancies is an appealing therapeutic and preventative method. As a result, top market players are investing in immunotherapy research and development to treat various tumors. In March 2019, for example, FUJIFILM Corporation and the National Cancer Center Japan announced the start of a joint research effort for novel cancer immunotherapy employing a liposome formulation. Immunotherapy has a stronger market adoption due to its success in terms of efficient treatment, which results in better patient outcomes. As a result, this contributes to market growth.

Which region accounted for the largest share in Oncology Market?

In 2021, North America is expected to have the biggest share of the global oncology market. The region's dominance is due to the increased incidence and prevalence of cancer in the United States, as well as new product introductions in the region. According to the National Cancer Institute, roughly 1.8 million people in the United States will be diagnosed with cancer in 2020. Europe, after North America, is expected to account for the second-largest share of the global market. Because of the rising cancer burden, high-growth countries such as the United Kingdom, Germany, France, Italy, and Spain will contribute to the expansion of the European oncology market. Because of increased population awareness, the Asia Pacific oncology market is likely to grow at a quicker rate. The rising prevalence of cancer and rising healthcare costs will boost regional growth. Latin America, the Middle East, and Africa are projected to see sluggish development due to a lack of awareness and affordability of high-cost biologic medications.

Top Oncology Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Oncology Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Oncology industry players.

Oncology Market Competitive Landscape

The oncology market is fragmented in nature. The prominent players operating in the market are constantly adopting various growth strategies in order to stay afloat in the market. Product launches, innovations, mergers, and acquisitions, collaborations and partnerships, and intensive R&D are some of the growth strategies that are adopted by these key players to thrive in the competitive market. The key market players are also constantly focused on R&D in order to supply industries with the most efficient and cost-effective solutions.

Oncology Market Top Company Profiles

Roche Holding AG
Novartis International AG
Bristol-Myers Squibb Company
Pfizer Inc.
Merck & Co., Inc.
AstraZeneca PLC
Johnson & Johnson
Sanofi S.A.
Takeda Pharmaceutical Company Limited
Amgen Inc.
AbbVie Inc.
Eli Lilly and Company
Gilead Sciences, Inc.
Celgene Corporation (a subsidiary of Bristol-Myers Squibb Company)
Bayer AG
Biogen Inc.
Daiichi Sankyo Company, Limited
Astellas Pharma Inc.
Eisai Co., Ltd.
Teva Pharmaceutical Industries Ltd.

REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?

REQUEST FREE CUSTOMIZATION

FAQs

Oncology Market size was valued at USD 249.53 Billion in 2024 and is poised to grow from USD 277.48 Billion in 2025 to USD 648.73 Billion by 2033, growing at a CAGR of 11.2% during the forecast period (2026–2033).

Key vendors in the Oncology Market include F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bristol Myers Squibb Company, Pfizer Inc., Novartis AG, AstraZeneca PLC, Johnson & Johnson, Eli Lilly and Company, AbbVie Inc., and Amgen Inc.. These companies are focused on developing targeted therapies, immunotherapies, chemotherapy drugs, and precision oncology solutions for the treatment of various cancer types worldwide.

The key driver of the Oncology Market is the rising global prevalence of cancer and the increasing demand for effective cancer treatment solutions. Growing adoption of targeted therapies, immunotherapies, and precision medicine approaches, along with advancements in cancer diagnostics and drug development, are significantly driving market growth worldwide.

The key market trend in the Oncology Market is the increasing adoption of precision medicine and immunotherapy for cancer treatment. Advances in biomarker-based diagnostics, targeted therapies, CAR-T cell therapies, and immune checkpoint inhibitors are enabling more personalized and effective treatment approaches, improving patient outcomes and driving innovation across the oncology landscape.

North America accounted for the largest share in the Oncology Market due to the high prevalence of cancer, advanced healthcare infrastructure, substantial investments in oncology research, and strong adoption of innovative cancer therapies. The presence of leading pharmaceutical companies, favorable reimbursement policies, and increasing availability of precision medicine and immunotherapy treatments further support regional market dominance.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Luca Giovannini, Marketing Innovation Senior Manager, Trelleborg.

Top Oncology Companies

Oncology Market Competitive Landscape

FAQs

What is the global market size of Oncology Market?

Who are the key vendors in the Oncology Market?

What is the key driver of Oncology Market?

What is the key market trend for Oncology Market?

Which region accounted for the largest share in Oncology Market?

Request Free Customization